Evidence map›Paper›PMID 38974655›Full record

ReviewFrontiers in bioengineering and biotechnology2024

Biomaterials for extrusion-based bioprinting and biomedical applications.

Arianna Rossi, Teresa Pescara, Alberto Maria Gambelli, Francesco Gaggia, Amish Asthana, Quentin Perrier, Giuseppe Basta, Michele Moretti, Nicola Senin, Federico Rossi and 2 more

Abstract readReview
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Arianna RossiSmart Manufacturing Laboratory, Engineering Department, University of Perugia, Perugia, Italy.
Teresa PescaraLaboratory for Endocrine Cell Transplant and Biohybrid Organs, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
Alberto Maria GambelliDepartment of Civil and Environmental Engineering, University of Perugia, Perugia, Italy.
Francesco GaggiaLaboratory for Endocrine Cell Transplant and Biohybrid Organs, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
Amish AsthanaWake Forest School of Medicine, Winston Salem, NC, United States.
Quentin PerrierWake Forest School of Medicine, Winston Salem, NC, United States.
Giuseppe BastaLaboratory for Endocrine Cell Transplant and Biohybrid Organs, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
Michele MorettiSmart Manufacturing Laboratory, Engineering Department, University of Perugia, Perugia, Italy.
Nicola SeninSmart Manufacturing Laboratory, Engineering Department, University of Perugia, Perugia, Italy.
Federico RossiEngineering Department, University of Perugia, Perugia, Italy.
Giuseppe OrlandoWake Forest School of Medicine, Winston Salem, NC, United States.
Riccardo CalafioreDiabetes Research Foundation, Confindustria Umbria, Perugia, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amongst the range of bioprinting technologies currently available, bioprinting by material extrusion is gaining increasing popularity due to accessibility, low cost, and the absence of energy sources, such as lasers, which may significantly damage the cells. New applications of extrusion-based bioprinting are systematically emerging in the biomedical field in relation to tissue and organ fabrication. Extrusion-based bioprinting presents a series of specific challenges in relation to achievable resolutions, accuracy and speed. Resolution and accuracy in particular are of paramount importance for the realization of microstructures (for example, vascularization) within tissues and organs. Another major theme of research is cell survival and functional preservation, as extruded bioinks have cells subjected to considerable shear stresses as they travel through the extrusion apparatus. Here, an overview of the main available extrusion-based printing technologies and related families of bioprinting materials (bioinks) is provided. The main challenges related to achieving resolution and accuracy whilst assuring cell viability and function are discussed in relation to specific application contexts in the field of tissue and organ fabrication.

Indexed as

artificial tissuesbiomaterialsbiomedical applicationsbioprintingmaterial extrusion

Identifiers

PMID38974655
PMCPMC11225062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.